Skip to content
BidBenchmark

Contract award

LEIDOS BIOMEDICAL RESEARCH INC

NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES
PIID
75N91022F00016
Award key
CONT_AWD_75N91022F00016_7529_75N91019D00024_7529
Recipient UEI
HV8BH9BPG8Y9
Parent award
CONT_IDV_75N91019D00024_7529
Source as of
—
Current award value
$13,973,7443
Obligated to date
$13,973,7442
Potential with options
$13,973,7443
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Frederick, Maryland
Set-aside
None
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition
Period of performance
Sep 12, 2022 — Sep 11, 2027Through Sep 11, 2029 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 9, 2022Initial award$9,308,321.00$13,973,744.00
P00001Sep 19, 2024D$2,448,234.00$13,973,744.00
P00002Jun 9, 2025F$0.00$13,973,744.00
P00003Sep 3, 2025F-$220,697.00$13,973,744.00
P00004Sep 23, 2026M$2,437,886.00$13,973,744.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.gov—Sep 26, 2026usaspending_contract_csv@2026.08.24a8504ec13f1
contractor_idUSAspending.gov—Sep 26, 2026usaspending_contract_csv@2026.08.24a8504ec13f1
current_award_valueUSAspending.gov—Sep 26, 2026usaspending_contract_csv@2026.08.24a8504ec13f1
naics_codeUSAspending.gov—Sep 26, 2026usaspending_contract_csv@2026.08.24a8504ec13f1
potential_award_valueUSAspending.gov—Sep 26, 2026usaspending_contract_csv@2026.08.24a8504ec13f1
psc_codeUSAspending.gov—Sep 26, 2026usaspending_contract_csv@2026.08.24a8504ec13f1
total_obligatedUSAspending.gov—Sep 26, 2026usaspending_contract_csv@2026.08.24a8504ec13f1

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 5 transaction records parsed from USAspending.gov, retrieved Sep 26, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75N91022F00016 — LEIDOS BIOMEDICAL RESEARCH INC · BidBenchmark